Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11448895 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Erlotinib and Temsirolimus for Solid Tumors
Condition: Solid Tumors
Interventions: Drug: Erlotinib;   Drug: Temsirolimus

Indicates status has not been verified in more than two years